Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Implementation of [18F]-labeled amyloid brain PET imaging biomarker in the diagnosis of Alzheimer's disease: first-hand experience in Thailand.
Nucl Med Commun. 2018 Feb;39(2):186-192. doi: 10.1097/MNM.0000000000000787.
Nucl Med Commun. 2018.
PMID: 29334579
No abstract available.
Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer's disease.
Thientunyakit T, Sethanandha C, Muangpaisan W, Chawalparit O, Arunrungvichian K, Siriprapa T, Vichianin Y, Kamal S, Suppasilp C, Thongpraparn T, Chanachai R, Gelovani JG.
Thientunyakit T, et al. Among authors: siriprapa t.
Ann Nucl Med. 2020 May;34(5):337-348. doi: 10.1007/s12149-020-01453-y. Epub 2020 Mar 9.
Ann Nucl Med. 2020.
PMID: 32152925
Clinical Trial.
Item in Clipboard
Head-to-head comparison of [18F]-fluorodeoxyglucose and [18F]-fluorocholine positron emission tomography/computed tomography in three patients with rare gestational trophoblastic neoplasms: A case series.
Thientunyakit T, Thongpraparn T, Siriprapa T, Gelovani JG.
Thientunyakit T, et al. Among authors: siriprapa t.
World J Nucl Med. 2019 Jul 23;19(1):72-77. doi: 10.4103/wjnm.WJNM_91_18. eCollection 2020 Jan-Mar.
World J Nucl Med. 2019.
PMID: 32190029
Free PMC article.
Item in Clipboard
Cite
Cite